eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Share:
Send email
Share:
Review paper

Modern biomarkers in IgA vasculitis with nephritis in children

Karolina Cichoń-Kawa
1
,
Emilia Płatos
1, 2
,
Wojciech Wasiak
2
,
Małgorzata Mizerska-Wasiak
1

  1. Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
  2. Student’s Scientific Group of the Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw, Poland
Cent Eur J Immunol 2024; 49
DOI: https://doi.org/10.5114/ceji.2024.143443
Online publish date: 2024/09/27
Article file
- Modern biomarkers.pdf  [0.26 MB]
Get citation
 
PlumX metrics:
 
1. Piram M, Mahr A (2013): Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol 25: 171-178.
2. Heineke MH, Ballering AV, Jamin A, et al. (2017): New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Autoimmun Rev 16: 1246-1253.
3. Demir S, Kaplan O, Celebier M, et al. (2020): Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. Semin Arthritis Rheum 50: 1238-1244.
4. Ozen S, Pistorio A, Iusan SM, et al. (2010): EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69: 798-806.
5. Mizerska-Wasiak M, Kusztal M. Zapalenie naczyń związane z IgA. In: Zapalenia naczyń w praktyce klinicznej interdyscyplinarnie. Kołacz A, Kossarzecka E (Eds.). PZWL Wydawnictwo Lekarskie, Warszawa 2022; 416-418.
6. Sestan M, Jelusic M (2023): Diagnostic and management strategies of IgA vasculitis nephritis/Henoch-Schönlein purpura nephritis in pediatric patients: Current perspectives. Pediatric Health Med Ther 14: 89-98.
7. Komatsu H, Fujimoto S, Yoshikawa N, et al. (2016): Clinical manifestations of Henoch- Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 20: 552-560.
8. Delbet JD, Parmentier C, Rea CH, et al. (2021): Management of IgA vasculitis with nephritis. Pediatric Drugs 23: 425-435.
9. Pohl M (2015): Henoch-Schönlein purpura nephritis. Pediatr Nephrol 30: 245-252.
10. Dyga K, Szczepańska M (2020): IgA vasculitis with nephritis in children. Adv Clin Exp Med 29: 513-519.
11. Pillebout E, Jamin A, Ayari H, et al. (2017): Biomarkers of IgA vasculitis nephritis in children. PLoS One 12: e0188718.
12. Shi D, Chan H, Yang X, et al. (2019): Risk factors associated with IgA vasculitis with nephritis (Henoch-Schonlein purpura nephritis) progressing to unfavorable outcomes: A meta-analysis. PLoS One 14: e0223218.
13. Mizerska-Wasiak M, Turczyn A, Cichoń-Kawa K, et al. (2021): IgA vasculitis nephritis clinical course and kidney biopsy – national study in children. Pediatric Rheumatology 19: 150.
14. Edstrom-Halling S, Soderberg MP, Berg UB (2010): Predictors of outcome in Henoch-Schonlein nephritis. Pediatr Nephrol 25: 1101-1108.
15. Kawasaki Y, Suzuki J, Sakai N, et al. (2003): Clinical and pathological features of children with Henoch-Schonlein nephritis: risk factors associated with poor prognosis. Clin Nephrol 60: L153-160.
16. Mir S, Yavascan O, Mutlubas F, et al. (2007): Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol 22: 64-70.
17. Chan H, Tang YL, Lv XH, et al. (2016): Risk factors associated with renal involvement in childhood Henoch-Schonlein purpura: a meta-analysis. PLoS One 11: e0167346.
18. Jelusic M, Sestan M, Cimaz R, et al. (2019): Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Pediatr Rheumatol 17: 10.
19. Trimarchi H, Barratt J, Cattran DC, et al. (2017): IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Conference Participants. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int 91: 1014-1021.
20. Jelusic M, Sestan M, Giani T, Cimaz R (2022): New insights and challenges associated with IgA vasculitis and IgA vasculitis with nephritis – is it time to change the paradigm of the most common systemic vasculitis in childchood? Front Pediatr 10: 853724.
21. Pan YX, Ye Q, Shao WX, et al. (2014): Relationship between immune parameters and organ involvement in children with Henoch-Schönlein purpura. PLoS One 9: e115261.
22. Chen XQ, Tu L, Tang Q, et al. (2022): An emerging role for neutrophil extracellular traps in IgA vasculitis: A mini-review. Front Immunol 13: 912929.
23. Suzuki H, Yasutake J, Makita Y, et al. (2018): IgA nephropathy and Iga vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int 93: 700-705.
24. Nusken E, Weber LT (2022): IgA vasculitis nephritis. Curr Opin Pediatr 34: 209-216.
25. Peruzzi L, Coppo R (2021): IgA vasculitis nephritis in children and adults: one or different entities? Pediatr Nephrol 36: 2615-2625.
26. Suzuki H, Kiryluk K, Novak J (2011): The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22: 1795-1803.
27. Chua JS, Zandbergen M, Wolterbeek R, et al. (2019): Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol 32: 1147-1157.
28. Imai T, Nishiyama K, Ueki K, et al. (2020): Involvement of activated cytotoxic T lymphocytes and natural killer cells in Henoch-Schonlein purupura nephritis. Clin Transl Immunology 9: e1212.
29. Hastings MC, Rizk DV, Kiryluk K, et al. (2022): IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol 37: 719-733.
30. Morton HC, Brandtzaeg P (2001): CD89: the human myeloid IgA Fc receptor. Arch Immunol Ther Exp 49: 217-229.
31. Haddad E, Moura IC, Arcos-Fajardo M, et al. (2003): Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits. J Am Soc Nephrol 14: 327-337.
32. Wang J, Ying Q, Zhong S, et al. (2018): Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis. Pediatr Neonatol 59: 238-243.
33. Davin JC, Coppo R (2014); Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol 10: 563.
34. He X, Yu C, Zhao P, et al. (2013): The genetics of Henoch-Schonlein purpura: a systematic review and meta-analysis. Rheumatol Int 33: 1387-1395.
35. Oni L, Sampath S (2019): Childhood IgA vasculitis (Henoch-Schonlein purpura) – advances and knowledge gaps. Fron Pediatr 7: 257.
36. Berthelot L, Jamin A, Viglietti D, et al. (2018): Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant 33: 1579-1590.
37. Larson H, Chan E, Sudarsanam S, Johnson DE (2013): Biomarkers. Methods Mol Biol 930: 253-273.
38. Mizerska-Wasiak M, Gajewski Ł, Cichoń-Kawa K, et al. (2018): Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schönlein nephritis. Cent Eur J Immunol 43: 162-167.
39. Zhang X, Xie X, Shi S, et al. (2020): Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis. Nephrol Dial Transplant 35: 2117-2123.
40. Suzuki H, Moldoveanu Z, Julian BA, et al. (2019): Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis. Kidney Int Rep 4: 1717-1724.
41. An JK, Xia D (2018): Diagnostic performance of urinary proteins as biomarkers in evaluating Henoch Schonlein purpura nephritis. Clin Exp Med 11: 12354-12360.
42. Mayer-Hain S, Gebhardt K, Neufeld M, et al. (2022): Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis. J Immunol 209: 1048-1058.
43. Coppo R, Basolo B, Martina G, et al. (1982): Circulating Immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18: 230-239.
44. Davin JC, Ten Berge IJ, Weening JJ (2001): What the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59: 823-834.
45. Monteiro RC, Kubagawa H, Cooper MD (1990): Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J Exp Med 171: 597-613.
46. Moresco RN, Speeckaert MM, Zmonarski SC, et al. (2016): Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and Henoch-Schönlein purpura nephritis. BBA Clin 5: 79-84.
47. Delanghe SE, Speeckaert MM, Segers H, et al. (2013): Soluble transferrin receptor in urine, a new biomarker for IgA nephropathy and Henoch-Schönlein purpura nephritis. Clin Biochem 46: 591-597.
48. Williams CEC, Toner A, Wright RD, Oni L (2021): A systematic review of urine biomarkers in children with IgA vasculitis nephritis. Pediatr Nephrol 36: 3033-3044.
49. Zhang R, Sung SHP, Feng G, et al. (2018): Aggregation-induced emission probe for specific turn-on quantification of soluble transferrin receptor: An important disease marker for iron deficiency anemia and kidney diseases. Anal Chem 90: 1154-1160.
50. Zhang Q, Yan L, Chen M, et al. (2019): IgA1 isolated from Henoch-Schönlein purpura children promotes proliferation of human mesangial cells in vitro. Cell Biol Int 43: 760-769.
51. Yuan L, Wang Q, Zhang S, Zhang L (2018): Correlation between serum inflammatory factors TNF-, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment. Exp Ther Med 15: 3924-3928.
52. Lin CY, Yang YH, Lee CC, et al. (2006): Thrombopoietin and interleukin-6 levels in Henoch-Schonlein purpura. J Microbiol Immunol 39: 476-482.
53. Kimura S, Takeuchi S, Soma Y, Kawakami T (2013): Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura. Clin Exp Dermatol 38: 730-736.
54. Marro J, Chetwynd AJ, Wright RD, et al. (2022): Urinary protein array analysis to identify key inflammatory markers in children with IgA vasculitis nephritis. Children 9: 622.
55. Dyga K, Machura E, Swietochowska E, Szczepańska M (2020): Analysis of the association between kidney injury biomarkers concentration and nephritis in immunoglobulin A vasculitis: A pediatric cohort study. Int J Rheum Dis 23: 1184-1193.
56. Mao YN, Liu WEI, Li YG, et al. (2012): Urinary angiotensinogen levels in relation to renal involvement of Henoch-Schonlein purpura in children. Nephrology 17: 53-57.
57. Yi-fei M, Yu-feng L, Gui-mei G, et al. (2020): Changes of new urinary biomarkers in children with Henoch-Schonlein purpura nephritis. J Shanghai Jiaotong Univ Med Sci 40: 841.
58. Shuiai Z, Huijun S, Weizhong G, et al. (2017): Evaluation of TGF-b1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schonlein purpura nephritis and IgA nephropathy: A clinical correlation. Clinics 72: 95-102.
59. Fuentes Y, Hernandes AM, Garci-Roca P, et al. (2014): Urinary MCP-1/creatinine in Henoch-Schonlein purpura and its relationship with nephritis. Pediatr Nephrol 29: 1047-1052.
60. Mizerska-Wasiak M, Płatos E, Cichoń-Kawa K, et al. (2022): The usefulness of vanin-1 and periostin as markers of an active autoimmune process or renal fibrosis in children with IgA nephropathy and IgA vasculitis with nephritis – a pilot study. J Clin Med 11: 1265.
61. Demir S, Kaplan O, Celebier M, et al. (2020): Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. Semin Arthritis Rheum 50: 1238-1244.
62. Sun L, Xie B, Zhang Q, et al. (2017): Biomarkers identification by a combined clinical and metabonomics analysis in Henoch-Schonlein purpura nephritis children. Oncotarget 8: 114239-114250.
63. Coppo R, Fonsato V, Balegno S, et al. (2010): Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int 77: 417-427.
Copyright: © 2024 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.